These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 37681920)

  • 1. A Protocol for Organoids from the Urine of Bladder Cancer Patients.
    Walz S; Pollehne P; Geng R; Schneider J; Maas M; Aicher WK; Stenzl A; Amend B; Harland N
    Cells; 2023 Aug; 12(17):. PubMed ID: 37681920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishment of a novel experimental model for muscle-invasive bladder cancer using a dog bladder cancer organoid culture.
    Elbadawy M; Usui T; Mori T; Tsunedomi R; Hazama S; Nabeta R; Uchide T; Fukushima R; Yoshida T; Shibutani M; Tanaka T; Masuda S; Okada R; Ichikawa R; Omatsu T; Mizutani T; Katayama Y; Noguchi S; Iwai S; Nakagawa T; Shinohara Y; Kaneda M; Yamawaki H; Sasaki K
    Cancer Sci; 2019 Sep; 110(9):2806-2821. PubMed ID: 31254429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishment of 2.5D organoid culture model using 3D bladder cancer organoid culture.
    Abugomaa A; Elbadawy M; Yamanaka M; Goto Y; Hayashi K; Mori T; Uchide T; Azakami D; Fukushima R; Yoshida T; Shibutani M; Yamashita R; Kobayashi M; Yamawaki H; Shinohara Y; Kaneda M; Usui T; Sasaki K
    Sci Rep; 2020 Jun; 10(1):9393. PubMed ID: 32523078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Establishment of an experimental model of normal dog bladder organoid using a three-dimensional culture method.
    Elbadawy M; Fujisaka K; Yamamoto H; Tsunedomi R; Nagano H; Ayame H; Ishihara Y; Mori T; Azakami D; Uchide T; Fukushima R; Abugomaa A; Kaneda M; Yamawaki H; Shinohara Y; Omatsu T; Mizutani T; Usui T; Sasaki K
    Biomed Pharmacother; 2022 Jul; 151():113105. PubMed ID: 35605292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urine-derived bladder cancer organoids (urinoids) as a tool for cancer longitudinal response monitoring and therapy adaptation.
    Viergever BJ; Raats DAE; Geurts V; Mullenders J; Jonges TN; van der Heijden MS; van Es JH; Kranenburg O; Meijer RP
    Br J Cancer; 2024 Feb; 130(3):369-379. PubMed ID: 38102228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Scaffolds on Urine- and Urothelial Carcinoma Tissue-Derived Organoids from Bladder Cancer Patients.
    Walz S; Pollehne P; Vollmer P; Aicher WK; Stenzl A; Harland N; Amend B
    Cells; 2023 Aug; 12(16):. PubMed ID: 37626918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient-derived bladder cancer organoids show stable transcript expression along cultivation.
    Vollmer P; Amend B; Harland N; Stenzl A; Tsaur I; Maas M; Aicher WK; Walz S
    World J Urol; 2024 Aug; 42(1):468. PubMed ID: 39110253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-tumor effect of trametinib in bladder cancer organoid and the underlying mechanism.
    Elbadawy M; Sato Y; Mori T; Goto Y; Hayashi K; Yamanaka M; Azakami D; Uchide T; Fukushima R; Yoshida T; Shibutani M; Kobayashi M; Shinohara Y; Abugomaa A; Kaneda M; Yamawaki H; Usui T; Sasaki K
    Cancer Biol Ther; 2021 Jun; 22(5-6):357-371. PubMed ID: 34034619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LC-MS metabolomics of urine reveals distinct profiles for non-muscle-invasive and muscle-invasive bladder cancer.
    Oto J; Fernández-Pardo Á; Roca M; Plana E; Cana F; Herranz R; Pérez-Ardavín J; Vera-Donoso CD; Martínez-Sarmiento M; Medina P
    World J Urol; 2022 Oct; 40(10):2387-2398. PubMed ID: 36057894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urothelial cancer organoids: a tool for bladder cancer research.
    Meijer RP
    Pathologe; 2021 Dec; 42(Suppl 2):165-169. PubMed ID: 34623463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bladder Cancer Patient-derived Organoids and Avatars for Personalized Cancer Discovery.
    Kim YS; Hsieh AC; Lam HM
    Eur Urol Focus; 2022 May; 8(3):657-659. PubMed ID: 35915037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A noninvasive urine-based methylation biomarker panel to detect bladder cancer and discriminate cancer grade.
    Hermanns T; Savio AJ; Olkhov-Mitsel E; Mari A; Wettstein MS; Saba K; Bhindi B; Kuk C; Poyet C; Wild PJ; Noon A; Bashir S; Juvet T; Rendon RA; Waltregny D; van der Kwast T; Finelli A; Kulkarni GS; Fleshner NE; Lo K; Bapat B; Zlotta AR
    Urol Oncol; 2020 Jun; 38(6):603.e1-603.e7. PubMed ID: 32081560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate Cancer Organoids for Tumor Modeling and Drug Screening.
    Yehya A; Ghamlouche F; Hachem S; Abou-Kheir W
    Methods Mol Biol; 2024; 2777():135-144. PubMed ID: 38478341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Data-Driven Identification of Biomarkers for In Situ Monitoring of Drug Treatment in Bladder Cancer Organoids.
    Becker L; Fischer F; Fleck JL; Harland N; Herkommer A; Stenzl A; Aicher WK; Schenke-Layland K; Marzi J
    Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35805961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microchips for detection of exfoliated tumor cells in urine for identification of bladder cancer.
    Liang L; Wang Y; Lu S; Kong M; Lin Y; Cuzzucoli F; Wang P; Wang S
    Anal Chim Acta; 2018 Dec; 1044():93-101. PubMed ID: 30442409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The role of telomerase activity in non-invasive diagnostics of bladder cancer].
    Glybochko PV; Alyaev JG; Potoldykova NV; Polyakovsky KA; Vinarov AZ; Glukhov AI; Gordeev SA
    Urologiia; 2016 Aug; (4):76-81. PubMed ID: 28247730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Global Meta-analysis of Urine Microbiome: Colonization of Polycyclic Aromatic Hydrocarbon-degrading Bacteria Among Bladder Cancer Patients.
    Bukavina L; Isali I; Ginwala R; Sindhani M; Calaway A; Magee D; Miron B; Correa A; Kutikov A; Zibelman M; Ghannoum M; Retuerto M; Ponsky L; Markt S; Uzzo R; Abbosh P
    Eur Urol Oncol; 2023 Apr; 6(2):190-203. PubMed ID: 36868921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary Exosomal miRNAs as biomarkers of bladder Cancer and experimental verification of mechanism of miR-93-5p in bladder Cancer.
    Lin H; Shi X; Li H; Hui J; Liu R; Chen Z; Lu Y; Tan W
    BMC Cancer; 2021 Dec; 21(1):1293. PubMed ID: 34861847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of multiple mutations in urinary exfoliated cells from male bladder cancer patients at diagnosis and during follow-up.
    Critelli R; Fasanelli F; Oderda M; Polidoro S; Assumma MB; Viberti C; Preto M; Gontero P; Cucchiarale G; Lurkin I; Zwarthoff EC; Vineis P; Sacerdote C; Matullo G; Naccarati A
    Oncotarget; 2016 Oct; 7(41):67435-67448. PubMed ID: 27611947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of telomerase activity in exfoliated cells in urine from patients with bladder cancer.
    Kinoshita H; Ogawa O; Kakehi Y; Mishina M; Mitsumori K; Itoh N; Yamada H; Terachi T; Yoshida O
    J Natl Cancer Inst; 1997 May; 89(10):724-30. PubMed ID: 9168188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.